When do you recommend PMRT for individuals with spindle cell carcinoma of the breast?   

Do you use the typical indications for PMRT (nodal status, size of primary, LVSI, age, etc)?  Or,  do you recommended PMRT more frequently (even in the node-negative setting) given the histology is potentially more similar to a sarcoma than a carcinoma?"



Answer from: Radiation Oncologist at Community Practice